Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Robert W Moses Insider Profile
4 Followers
Robert W Moses, Director at Antisense Therapeutics Limited, holds 9.09M shares in Antisense Therapeutics Limited (Ticker: ATHJF). Most recently, Robert W Moses ― shares of Antisense Therapeutics Limited on ― for an estimated value of ―.
Robert W Moses has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Robert W Moses's holdings
Insider Roles
Director
Roles that Robert W Moses holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Robert W Moses
Robert W Moses's Trading History
List of latest transactions for each holding click on a transaction to see Robert W Moses's performance on stock
You May Also Like
Robert W Moses insider profile FAQ
What is the percentage of profitable transactions made by Robert W Moses?
The percentage of profitable transactions made by Robert W Moses is ―.
What is the average return per transaction made by Robert W Moses?
The average return per transaction made by Robert W Moses is ―.
What stocks does Robert W Moses hold?
Robert W Moses holds: ATHJF stocks.
What was Robert W Moses’s latest transaction?
Robert W Moses latest transaction was an Uninformative Buy of ―.
What was Robert W Moses's most profitable transaction?
Robert W Moses’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Robert W Moses's role in Antisense Therapeutics Limited?
Robert W Moses's role in Antisense Therapeutics Limited is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.